Advertisement

International Journal of Clinical Pharmacy

, Volume 36, Issue 4, pp 702–706 | Cite as

Drug-related problems identified by pharmacists conducting medication use reviews at a primary health center in Qatar

  • Nadir KheirEmail author
  • Ahmed Awaisu
  • Amal Sharfi
  • Maha Kida
  • Abdullah Adam
Short Research Report

Abstract

Background Medication use review (MUR) is increasingly being recognized globally as a routine strategy performed by pharmacists to optimize the therapeutic outcomes of long-term medications. MUR services are not commonly available in hospitals and primary health care (PHC) centers in Qatar and no previous studies have reported the nature and extent of such services where they exist. Objective To describe the extent and types of drug-related problems (DRPs) generated from MUR interactions conducted at a PHC facility in Qatar and to determine the effect of patient characteristics on the number of DRPs. Method This was a cross-sectional, descriptive and exploratory study. Data were generated and documented prospectively via semi-private interviews conducted by intervention pharmacists (n = 6). DRPs identified were categorized according to the Pharmaceutical Care Network of Europe DRP classification system. Results In 56 medication reviews conducted, a total of 173 DRPs were identified with an average of 3.3 DRPs per patient. The most commonly encountered DRPs were non-adherence (31 %), need for education (23 %), and adverse drug reactions (21 %). Patients receiving six or more medications had significantly higher number of DRPs compared to those receiving three medications (p ≤ 0.05). Furthermore, elderly patients tended to have more DRPs compared to younger patients and there was a linear relationship between age and DRPs. Conclusion This study shows that patients receiving polypharmacy and the elderly in Qatar are vulnerable to experiencing DRPs, many of which are potentially preventable through MURs.

Keywords

Drug-related problems DRPs Medication review Medication utilization review MUR Pharmacy Qatar 

Notes

Acknowledgments

The authors would like to thank all pharmacists who provided the MUR services and the patients who participated in the study.

Funding

Funding was received from Qatar University under the Undergraduate Research Fund.

Conflicts of interest

None to declare.

References

  1. 1.
    Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.Google Scholar
  2. 2.
    Pharmaceutical Services Negotiating Committee. Medicines use review (MUR): the medicines use review and prescription intervention service [Online]. 2013 [cited 25 July 2013]; available from: http://psnc.org.uk/services-commissioning/advanced-services/murs/). [Cited 25 Jul 2013].
  3. 3.
    Latif A, Pollock K, Boardman HF. Medicines use reviews: a potential resource or lost opportunity for general practice? BMC Fam Pract. 2013;14:57.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Brossoie N, Roberto KA, Barrow KM. Making sense of intimate partner violence in late life: comments from online news readers. Gerontologist. 2012;52(6):792–801.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Finkers F, Maring JG, Boersma F, Taxis K. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther. 2007;32(5):469–76.PubMedCrossRefGoogle Scholar
  6. 6.
    Khalil H. A review of pharmacist recommendations in an aged care facility. Aust J Prim Health. 2011;17(1):35–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Latif A, Pollock K, Boardman HF. The contribution of the Medicines Use Review (MUR) consultation to counseling practice in community pharmacies. Patient Educ Couns. 2011;83(3):336–44.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    NHS. Clinical Medication Review [Online]. 2013 [cited 2013 Jul 1]. Available from: http://www.cumbria.nhs.uk/ProfessionalZone/MedicinesManagement/Guidelines/MedicationReview-PracticeGuide2011.pdf.
  9. 9.
    The PCNE DRP classification [Online]. 2010 [cited 2011 Apr 28]. Available from: http://www.pcne.org/sig/drp/drug-related-problems.php.
  10. 10.
    Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63(2):187–95.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Kempen T, Gompel C, Hoogland D, Bouvy LM. Drug related problems and interventions recorded in the Service Apotheek Medication Review Tool [Online]. 2013 [cited 30 Jul 2013]. Available from: http://vkc.library.uu.nl/vkc/upper/Lists/Events/DispForm.aspx?ID=186&ContentTypeId=0x01001C88203559EF0545BBF6EBEF79014029.

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Nadir Kheir
    • 1
    Email author
  • Ahmed Awaisu
    • 1
  • Amal Sharfi
    • 1
  • Maha Kida
    • 1
  • Abdullah Adam
    • 2
  1. 1.College of PharmacyQatar UniversityDohaQatar
  2. 2.Pharmacy Department, Medical ServicesQatar PetroleumDohaQatar

Personalised recommendations